Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 325

Results For "CRO"

3598 News Found

US FDA grants Jardiance Breakthrough Therapy designation for heart failure with a preserved ejection fraction
Biotech | September 12, 2021

US FDA grants Jardiance Breakthrough Therapy designation for heart failure with a preserved ejection fraction

The designation is based on results from the EMPEROR-Preserved phase III trial, which established Jardiance as the first therapy to show statistically significant improvement in heart failure outcomes in adults with heart failure with a preserved ejection fraction


Firstsource Solutions launch Healthcare Cloud
Digitisation | September 12, 2021

Firstsource Solutions launch Healthcare Cloud

The platform revolutionizes how providers deliver financial services by radically simplifying the patient financial experience


India develops Covid-19 vaccine tracker
News | September 10, 2021

India develops Covid-19 vaccine tracker

The tracker gives week by week coverage of the first and second dose of vaccine and also their effectiveness


Merck’s KEYTRUDA receives China approval for Esophageal cancer
Drug Approval | September 09, 2021

Merck’s KEYTRUDA receives China approval for Esophageal cancer

The medicine is now approved for eight indications across five different types of cancer in China.


Telangana commences drone delivery of vaccines from Sept 9
News | September 09, 2021

Telangana commences drone delivery of vaccines from Sept 9

The much-awaited drone delivery trials for the delivery of medicines and vaccines will be held in Vikarabad, Hyderabad from 9th September till 17th October.


Evexia Lifecare on expansion mode
News | September 09, 2021

Evexia Lifecare on expansion mode

The company plans to enter the formulation business in January 2022. It has also opened a branch in Hyderabad to trade pharmaceutical chemicals


Eirion Therapeutics mandates HTL Biotechnology to be its exclusive Botulinum API manufacturer.
Biotech | September 09, 2021

Eirion Therapeutics mandates HTL Biotechnology to be its exclusive Botulinum API manufacturer.

HTL will build, validate and operate a botulinum manufacturing facility in the US


Equipment shortage and overpriced APIs pinch the pharma industry
News | September 09, 2021

Equipment shortage and overpriced APIs pinch the pharma industry

A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges


RenovoRx receives New 510(k) clearance from US FDA
News | September 08, 2021

RenovoRx receives New 510(k) clearance from US FDA

The company’s RenovoCath Delivery System designed for targeted treatment of solid tumours


Giuliano Perfetti is the new CEO of Jubilant Biosys
Movement | September 08, 2021

Giuliano Perfetti is the new CEO of Jubilant Biosys

In his previous assignment Perfetti was associated with Fabbrica Italiana Sintetici (F.I.S) as Chief Commercial Officer